A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Status:
Completed
Trial end date:
2019-03-12
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of initiating treatment of schizophrenia with ARISTADA
INITIO plus 30 mg oral aripiprazole followed by a 2-month dose of AL.